Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Therapeutic Targets for Portal Hypertension
Éric Felli, Yelidousi Nulan, Sonia Selicean, et al.
Current Hepatology Reports (2023) Vol. 22, Iss. 1, pp. 51-66
Open Access | Times Cited: 15

Showing 15 citing articles:

Pathophysiology and therapeutic options for cirrhotic portal hypertension
Sergi Guixé‐Muntet, Sergio Quesada‐Vázquez, Jordi Gracia‐Sancho
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 7, pp. 646-663
Closed Access | Times Cited: 10
Preventing the progression of cirrhosis to decompensation and death
Cándid Villanueva, Dhiraj Tripathi, Jaime Bosch
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension
Michał Porada, Łukasz Bułdak
Metabolites (2025) Vol. 15, Iss. 2, pp. 72-72
Open Access
Vasomics of the liver
Chengyan Wang, Éric Felli, Jonathan A. Fallowfield, et al.
Gut (2025), pp. gutjnl-334133
Closed Access
Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management
Andrew Ndakotsu, Tagbo Charles Nduka, Simran Agrawal, et al.
Heart Failure Reviews (2025)
Closed Access
Antifibrotic Therapies for Metabolic Dysfunction-associated Steatotic Liver Disease
Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
JHEP Reports (2025), pp. 101421-101421
Open Access
Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
Danielle Adebayo, Florence Wong
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 10, pp. 1196-1211
Open Access | Times Cited: 2
Microarray analysis demonstrates upregulation of the endothelin-1 gene with compensatory downregulation of the ETA receptor gene in human portal vein
Nicola Owen, Thomas L. Williams, Janet J. Maguire, et al.
Bioscience Reports (2024) Vol. 44, Iss. 7
Open Access | Times Cited: 1
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jackie Bosch
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101233-101233
Open Access | Times Cited: 1
Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats, Cándid Villanueva
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 1055-1059
Open Access
Liver Sinusoidal Cells in alcohol-associated liver disease
Yasuko Iwakiri
Elsevier eBooks (2024), pp. 285-291
Closed Access
The liver sinusoid in chronic liver disease: NAFLD and NASH
Wilhelmus J. Kwanten, Sven Francque
Elsevier eBooks (2024), pp. 263-284
Closed Access
Changes in morphometric indicators of liver blood vessels under conditions of long-term ethanol exposure
A. О. Mykytenko, O. Ye. Akimov, G. А. Yeroshenko, et al.
Medicine Today and Tomorrow (2024) Vol. 93, Iss. 3
Closed Access
Joint Group and Multi Institutional Position Opinion: Cirrhotic Cardiomyopathy—From Fundamentals to Applied Tactics
Ivan Ranković, Ivana Babic, Jelena Nestorov, et al.
Medicina (2024) Vol. 61, Iss. 1, pp. 46-46
Open Access
Paneth cell: The missing link between obesity, MASH and portal hypertension
Minu Sajeev Kumar
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 48, Iss. 1, pp. 102259-102259
Closed Access
Page 1

Scroll to top